Literature DB >> 30260113

Analysis of quality antimicrobial agent use in the emergency department of a tertiary care hospital.

Fernando Oltra Hostalet1, María Núñez-Núñez2, María Del Mar Portillo Cano1, Carmen Navarro Bustos1, Jesús Rodríguez-Baño3, Pilar Retamar Gentil4.   

Abstract

OBJECTIVES: To describe modifiable factors related to inappropriate antimicrobial treatment in the observation area of an emergency department to explore practices that can be targeted for change through a program to improve emergency use of antimicrobial agents, the PROA program in its spanish observations.
MATERIAL AND METHODS: Cross-sectional serial point-prevalence study of all antimicrobial prescriptions for patients under observation in the department in February and March 2015.The main outcome measure was the frequency of antimicrobial treatment that was inappropriate according the center's guidelines. Two evaluators assessed appropriateness.
RESULTS: We analyzed 406 antimicrobial treatments. The main clinical syndromes were pneumonia (24%), urinary infections (22%), and nonpneumonia lower respiratory infections (22%). We found that 51.5% of the antimicrobial treatments were inappropriate. Factors associated with inappropriate prescriptions were a failure to analyze microbiologic samples before treating (61%), failure to specify the focus of infection in the case records (73%), and failure to meet the definition of sepsis (58%).
CONCLUSION: Fewer than half the antimicrobial treatments were appropriate as prescribed. Signs of serious infection, specification of the focus of infection in the patient's records, and the analysis of biologic samples were independent predictors of quality care (appropriate antimicrobial prescription). These factors can be targeted for training in the development of a specific emergency department program to improve this aspect of care.

Entities:  

Keywords:  Antibiotics; Antibióticos; Estudio de calidad; Health care quality; Hospital emergency health services; Servicios de urgencias hospitalarios

Mesh:

Substances:

Year:  2018        PMID: 30260113

Source DB:  PubMed          Journal:  Emergencias        ISSN: 1137-6821            Impact factor:   3.881


  5 in total

1.  A multidrug-resistant microorganism infection risk prediction model: development and validation in an emergency medicine population.

Authors:  Juan González Del Castillo; Agustín Julián-Jiménez; Julio Javier Gamazo-Del Rio; Eric Jorge García-Lamberechts; Ferrán Llopis-Roca; Josep María Guardiola Tey; Mikel Martínez-Ortiz de Zarate; Carmen Navarro Bustos; Pascual Piñera Salmerón; Jesús Álvarez-Manzanares; María Del Mar Ortega Romero; Martin Ruiz Grinspan; Susana García Gutiérrez; Francisco Javier Martín-Sánchez; Francisco Javier Candel González
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-13       Impact factor: 3.267

2.  [Strategies for improving the antibiotic treatment prescription in the Emergency Department].

Authors:  E Orviz; P Jerez-Fernández; M Suarez-Robles; C Ramos-Rey; I Armenteros; M Fernández-Revaldería; J González Del Castillo
Journal:  Rev Esp Quimioter       Date:  2020-01-14       Impact factor: 1.553

3.  [Predictive factors of bacteraemia in the patients seen in emergency departments due to infections].

Authors:  S Z Iqbal-Mirza; R Estévez-González; V Serrano-Romero de Ávila; E de Rafael González; E Heredero-Gálvez; A Julián-Jiménez
Journal:  Rev Esp Quimioter       Date:  2019-11-29       Impact factor: 1.553

4.  Determinants of empirical antipseudomonal antibiotic prescription for adults with pneumonia in the emergency department.

Authors:  Nuria Angrill; Miguel Gallego; Juli Font; Jordi Vallés; Anisi Morón; Eduard Monsó; Jordi Rello
Journal:  BMC Pulm Med       Date:  2020-04-03       Impact factor: 3.317

5.  [Adequacy of the special category antibiotics prescriptions in the Emergency Department of a third level urban Hospital].

Authors:  G Osorio; L Fresco; E Monclús; M Carbó; M Ortega
Journal:  Rev Esp Quimioter       Date:  2019-11-29       Impact factor: 1.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.